Impairment of right ventricular longitudinal strain associated with severity of pneumonia in patients recovered from COVID-19.


Journal

The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 20 01 2021
accepted: 01 03 2021
pubmed: 12 4 2021
medline: 5 8 2021
entrez: 11 4 2021
Statut: ppublish

Résumé

Myocardial injury caused by COVID-19 was reported in hospitalized patients previously. But the information about cardiac consequences of COVID-19 after recovery is limited. The aim of the study was comprehensive echocardiography assessment of right ventricular (RV) in patients recovered from COVID-19. This is a prospective, single-center study. After recovery from COVID-19, echocardiography was performed in consecutive 79 patients that attended follow-up visits from July 15 to November 30, 2020. According to the recovery at home vs hospital, patients were divided into two groups: home recovery (n = 43) and hospital recovery (n = 36). Comparisons were made with age, sex and risk factor-matched control group (n = 41). In addition to conventional echocardiography parameters, RV global longitudinal strain (RV-GLS) and RV free wall strain (RV-FWS) were determined using 2D speckle-tracking echocardiography (2D STE). Of the 79 patients recovered from COVID-19, 43 (55%) recovered at home, while 36 (45%) required hospitalization. The median follow-up duration was 133  ±  35 (87-184) days. In patients recovered from hospital, RV-GLS and RV-FWS were impaired compared to control group (RV-GLS: -17.3  ±  6.8 vs. -20.4  ±  4.9, respectively [p = 0.042]; RV-FWS: -19.0  ±  8.2 vs. -23.4  ±  6.2, respectively [p = 0.022]). In subgroup analysis, RV-FWS was impaired in patients severe pneumonia (n = 11) compared to mild-moderate pneumonia (n = 28), without pneumonia (n = 40) and control groups (-15.8  ±  7.6 vs. -21.6  ±  7.6 vs. -20.8  ±  7.7 vs. -23.4  ±  6.2, respectively, [p = 0.001 for each]) and RV-GLS was impaired compared to control group (-15.2  ±  6.9 vs. -20.4  ±  4; respectively, [p = 0.013]). A significant correlation was detected between serum CRP level at hospital admission and both RV-GLS and RV-FWS (r = 0.285, p = 0.006; r = 0.294, p = 0.004, respectively). Age (OR 0.948, p = 0.010), male gender (OR 0.289, p = 0.009), pneumonia on CT (OR 0.019, p = 0.004), and need of steroid in treatment (OR 17.424, p = 0.038) were identifed as independent predictors of impaired RV-FWS (> -18) via multivariate analysis. We demonstrated subclinic dysfunction of RV by 2D-STE in hospitalized patients in relation to the severity of pneumonia after recovery from COVID-19. 2D-STE supplies additional information above standard measures of RV in this cohort and can be used in the follow-up of these patients.

Identifiants

pubmed: 33839981
doi: 10.1007/s10554-021-02214-2
pii: 10.1007/s10554-021-02214-2
pmc: PMC8036243
doi:

Substances chimiques

Glucocorticoids 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2387-2397

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Références

JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Minerva Anestesiol. 2012 Aug;78(8):941-8
pubmed: 22672932
JAMA Cardiol. 2020 Jul 1;5(7):811-818
pubmed: 32219356
Circ Cardiovasc Imaging. 2018 Jan;11(1):e006894
pubmed: 29321212
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70
pubmed: 25712077
Dis Mon. 2020 Sep;66(9):101068
pubmed: 32907701
JAMA Cardiol. 2020 Nov 1;5(11):1281-1285
pubmed: 32730555
JAMA Cardiol. 2020 Jul 1;5(7):802-810
pubmed: 32211816
Circulation. 2020 May 19;141(20):1648-1655
pubmed: 32200663
Can J Cardiol. 2020 Aug;36(8):1203-1207
pubmed: 32474111
JACC Cardiovasc Imaging. 2020 Nov;13(11):2459-2461
pubmed: 32426088
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
JAMA Cardiol. 2020 Nov 1;5(11):1265-1273
pubmed: 32730619
J Am Soc Echocardiogr. 2017 Oct;30(10):937-946.e6
pubmed: 28803684
Int J Cardiovasc Imaging. 2021 Jan;37(1):135-144
pubmed: 32803484
Heart. 2010 May;96(9):716-22
pubmed: 20424157
Eur J Echocardiogr. 2011 Mar;12(3):167-205
pubmed: 21385887
Intensive Care Med. 2009 Jan;35(1):69-76
pubmed: 18839137
J Am Soc Echocardiogr. 2021 Feb;34(2):193-195
pubmed: 33243582
J Am Soc Echocardiogr. 2010 Jul;23(7):685-713; quiz 786-8
pubmed: 20620859
Eur Heart J. 2020 Oct 14;41(39):3827-3835
pubmed: 32968776
JACC Cardiovasc Imaging. 2020 Nov;13(11):2287-2299
pubmed: 32654963
J Am Coll Cardiol. 2020 Oct 27;76(17):1965-1977
pubmed: 33092732
JACC Cardiovasc Imaging. 2020 Nov;13(11):2330-2339
pubmed: 32763118
Echocardiography. 2015 Jun;32(6):966-74
pubmed: 25287078
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
J Am Soc Echocardiogr. 2019 Jan;32(1):1-64
pubmed: 30282592

Auteurs

Pelin Karaca Ozer (PK)

Istanbul Medical Faculty, Department of Cardiology, Istanbul University, Topkapi Mahallesi, Turgut Ozal Millet Caddesi, 34093, Fatih/Istanbul, Turkey. pkaracaozer@gmail.com.

Elif Ayduk Govdeli (EA)

Istanbul Medical Faculty, Department of Cardiology, Istanbul University, Topkapi Mahallesi, Turgut Ozal Millet Caddesi, 34093, Fatih/Istanbul, Turkey.

Derya Baykiz (D)

Istanbul Medical Faculty, Department of Cardiology, Istanbul University, Topkapi Mahallesi, Turgut Ozal Millet Caddesi, 34093, Fatih/Istanbul, Turkey.

Ekrem Bilal Karaayvaz (EB)

Istanbul Medical Faculty, Department of Cardiology, Istanbul University, Topkapi Mahallesi, Turgut Ozal Millet Caddesi, 34093, Fatih/Istanbul, Turkey.

Alpay Medetalibeyoglu (A)

Istanbul Medical Faculty, Department of Internal Medicine, Istanbul University, Istanbul, Turkey.

Yunus Catma (Y)

Istanbul Medical Faculty, Department of Internal Medicine, Istanbul University, Istanbul, Turkey.

Ali Elitok (A)

Istanbul Medical Faculty, Department of Cardiology, Istanbul University, Topkapi Mahallesi, Turgut Ozal Millet Caddesi, 34093, Fatih/Istanbul, Turkey.

Atahan Cagatay (A)

Istanbul Medical Faculty, Department of Infectious Diseases and Clinical Microbiology, Istanbul University, Istanbul, Turkey.

Berrin Umman (B)

Istanbul Medical Faculty, Department of Cardiology, Istanbul University, Topkapi Mahallesi, Turgut Ozal Millet Caddesi, 34093, Fatih/Istanbul, Turkey.

Aytac Oncul (A)

Istanbul Medical Faculty, Department of Cardiology, Istanbul University, Topkapi Mahallesi, Turgut Ozal Millet Caddesi, 34093, Fatih/Istanbul, Turkey.

Tufan Tukek (T)

Istanbul Medical Faculty, Department of Internal Medicine, Istanbul University, Istanbul, Turkey.

Zehra Bugra (Z)

Istanbul Medical Faculty, Department of Cardiology, Istanbul University, Topkapi Mahallesi, Turgut Ozal Millet Caddesi, 34093, Fatih/Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH